AmerisourceBergen - חוב כולל להון COR

Cencora, Inc. (COR) ensures the seamless operation of the healthcare system by supplying medications to pharmacies and hospitals. This daily debt-to-equity chart from GURU.Markets visualizes the liability balance, where the value 3.67 serves as the baseline indicator. Its status as an oligopolist with massive scale protects the business from competition, while demand for oncology drugs and expansion into veterinary medicine drive profit growth.

As a portfolio manager, I view this ratio as an indicator of financial stability. The metric compares total liabilities to net assets, determining the extent of the business's dependence on external borrowings. By analyzing the company's leverage history, an investor can see the balance between default risk and expansion rates. For Cencora, Inc. (COR), moderate leverage is critical when scaling biopharmaceutical distribution. Stable demand for medications allows the company to efficiently service its debt.